देश: नीदरलैंड
भाषा: अंग्रेज़ी
स्रोत: HMA (Heads of Medicines Agencies)
A/Moscow/10/99 (H3N2)-like virus aceglumate 0 %
Intervet UK Limited
QI01AB01
Suspension for injection
Salmonella vaccine
Chicken Broilers, Chicken Layers
2010-09-12
Revised: December 2010 AN: 00063/2010 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis Salenvac T Suspension for injection for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 0.5 ml: ACTIVE SUBSTANCES: Inactivated cells of _Salmonella _Enteritidis, strain PT 4: ≥ 1 RP* Inactivated cells of _Salmonella _Typhimurium, strain DT104: ≥ 1 RP* EXCIPIENTS: Adjuvant: aluminium hydroxide: 125 mg Preservative: thiomersal: 0.065 mg For a list of excipients, see section 6.1. * RP = relative potency = mean antibody response in rabbit potency test equal to or greater than a reference batch which was shown to be efficacious in chickens 3. PHARMACEUTICAL FORM Suspension for injection 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens (breeders and layers) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the active immunisation of chickens and the passive immunisation of the progeny to reduce caecum colonisation and faecal excretion with _S. _Enteritidis and _S. _Typhimurium_. _ Active immunity: Onset of immunity: 4 weeks after the second administration Duration of immunity: until approximately 56-60 weeks of age for chickens vaccinated at 12 and 16 weeks. Minor indication: In exceptional circumstances chickens from one day of age may be vaccinated in order to protect them in an environment where they are likely to become infected at an early stage in the rearing phase (epidemiologically indicated Revised: December 2010 AN: 00063/2010 Page 2 of 6 by recent outbreak of Salmonella or high infection pressure on the site). Onset of पूरा दस्तावेज़ पढ़ें